Mesenchymal stem cell

Phase 1
Lung Transplant
Intervention Type:
Intravenous (IV) Injection
Funder Type:
Organization | University

Drug Details

Mesenchymal stem cells derived from allogeneic, bone marrow.

Study Purpose

To assess the safety and feasibility of mesenchymal stem cells therapy in patients with transplant related bronchiolitis obliteran syndrome (BOS)

This drug has no clinical trials actively recruiting patients at this time.